- Home
- RLAY vs PLNT Comparison
RLAY vs PLNT Comparison
Compare RLAY & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | PLNT |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.2B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RLAY | PLNT |
|---|---|---|
| Price | $19.73 | $52.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $19.50 | ★ $107.46 |
| AVG Volume (30 Days) | ★ 4.2M | 1.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,355,000.00 | ★ $1,324,144,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | $324.03 | $11.66 |
| P/E Ratio | ★ N/A | $38.47 |
| Revenue Growth | ★ 53.44 | 12.06 |
| 52 Week Low | $3.03 | $37.03 |
| 52 Week High | $20.79 | $114.47 |
Technical Indicators
Market Signals| Indicator | RLAY | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 50.83 |
| Support Level | $12.10 | $49.36 |
| Resistance Level | $20.79 | $54.47 |
| Average True Range (ATR) | 1.31 | 1.47 |
| MACD | -0.09 | 0.21 |
| Stochastic Oscillator | 73.40 | 56.56 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.